UK court ruling pressures NHS to end long delays
This article was originally published in Clinica
The UK has come under renewed pressure to increase activity in surgery and other procedures, after the High Court this week ruled that the National Health Service is obliged to pay for non-NHS treatment of patients who suffer "undue delay".
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.